Cargando…

Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection

Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, multiple but rare complications of this infection have been described, comprising cerebral venous sinus thrombosis (CVST) and immune thrombocytopenic purpura (ITP). Although these two complications have been reported as separat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadorizadeh, Leyla, Emamikhah, Maziar, Pour Mohammad, Arash, Gholizadeh Mesgarha, Milad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554500/
https://www.ncbi.nlm.nih.gov/pubmed/34714517
http://dx.doi.org/10.1007/s40120-021-00294-9
_version_ 1784591813870354432
author Bahadorizadeh, Leyla
Emamikhah, Maziar
Pour Mohammad, Arash
Gholizadeh Mesgarha, Milad
author_facet Bahadorizadeh, Leyla
Emamikhah, Maziar
Pour Mohammad, Arash
Gholizadeh Mesgarha, Milad
author_sort Bahadorizadeh, Leyla
collection PubMed
description Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, multiple but rare complications of this infection have been described, comprising cerebral venous sinus thrombosis (CVST) and immune thrombocytopenic purpura (ITP). Although these two complications have been reported as separate entities, to the best of our knowledge, their concurrent presentation has not been reported. In this case report, we present a middle-aged man with a history of COVID-19 infection who developed a sudden-onset severe occipital headache followed by right-sided blindness (right homonymous hemianopia). Upon his diagnostic workup, brain computed tomography scan with and without contrast was indicative of thrombosis of the left transverse venous sinus and hemorrhagic venous infarction. In addition, laboratory data revealed thrombocytopenia, which upon investigation confirmed a diagnosis of ITP. We postulate three pathophysiological mechanisms for this circumstance: either COVID-19 infection caused ITP and then ITP gave rise to CVST, or COVID-19 complications themselves resulted in ITP and CVST independently and simultaneously, or another plausible mechanism is immune-mediated thrombocytopenia caused by the anti-platelet 4-factor antibody, which is the proposed mechanism for CVST after the COVID-19 vaccine.
format Online
Article
Text
id pubmed-8554500
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-85545002021-10-29 Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection Bahadorizadeh, Leyla Emamikhah, Maziar Pour Mohammad, Arash Gholizadeh Mesgarha, Milad Neurol Ther Case Report Since the emergence of the coronavirus disease 2019 (COVID-19) pandemic, multiple but rare complications of this infection have been described, comprising cerebral venous sinus thrombosis (CVST) and immune thrombocytopenic purpura (ITP). Although these two complications have been reported as separate entities, to the best of our knowledge, their concurrent presentation has not been reported. In this case report, we present a middle-aged man with a history of COVID-19 infection who developed a sudden-onset severe occipital headache followed by right-sided blindness (right homonymous hemianopia). Upon his diagnostic workup, brain computed tomography scan with and without contrast was indicative of thrombosis of the left transverse venous sinus and hemorrhagic venous infarction. In addition, laboratory data revealed thrombocytopenia, which upon investigation confirmed a diagnosis of ITP. We postulate three pathophysiological mechanisms for this circumstance: either COVID-19 infection caused ITP and then ITP gave rise to CVST, or COVID-19 complications themselves resulted in ITP and CVST independently and simultaneously, or another plausible mechanism is immune-mediated thrombocytopenia caused by the anti-platelet 4-factor antibody, which is the proposed mechanism for CVST after the COVID-19 vaccine. Springer Healthcare 2021-10-29 /pmc/articles/PMC8554500/ /pubmed/34714517 http://dx.doi.org/10.1007/s40120-021-00294-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Case Report
Bahadorizadeh, Leyla
Emamikhah, Maziar
Pour Mohammad, Arash
Gholizadeh Mesgarha, Milad
Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title_full Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title_fullStr Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title_full_unstemmed Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title_short Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
title_sort simultaneous occurrence of cerebral venous sinus thrombosis and immune thrombocytopenic purpura in a patient with a history of covid-19 infection
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554500/
https://www.ncbi.nlm.nih.gov/pubmed/34714517
http://dx.doi.org/10.1007/s40120-021-00294-9
work_keys_str_mv AT bahadorizadehleyla simultaneousoccurrenceofcerebralvenoussinusthrombosisandimmunethrombocytopenicpurpurainapatientwithahistoryofcovid19infection
AT emamikhahmaziar simultaneousoccurrenceofcerebralvenoussinusthrombosisandimmunethrombocytopenicpurpurainapatientwithahistoryofcovid19infection
AT pourmohammadarash simultaneousoccurrenceofcerebralvenoussinusthrombosisandimmunethrombocytopenicpurpurainapatientwithahistoryofcovid19infection
AT gholizadehmesgarhamilad simultaneousoccurrenceofcerebralvenoussinusthrombosisandimmunethrombocytopenicpurpurainapatientwithahistoryofcovid19infection